Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 5986 AL 6000

A systematic review of adverse events in the placebo arm of donepezil trials: the role of cognitive impairment

Amanzio M, Benedetti F, Vase L.

Int Psychogeriatr. 2012 May;24(5):698-707. doi: 10.1017/S1041610211002420. Epub 2012 Jan 4.

Withdrawal syndrome after donepezil cessation in a patient with dementia

Bidzan L, Bidzan M.

Neurol Sci. 2012 Dec;33(6):1459-61. doi: 10.1007/s10072-012-0938-8. Epub 2012 Jan 15.

Semantic memory and language dysfunction in early Alzheimer's disease: a review

Verma M, Howard RJ.

Int J Geriatr Psychiatry. 2012 Dec;27(12):1209-17. doi: 10.1002/gps.3766. Epub 2012 Feb 1.

Citalopram for agitation in Alzheimer's disease: design and methods

Drye LT, Ismail Z, Porsteinsson AP, Rosenberg PB, Weintraub D, Marano C, Pelton G, Frangakis C, Rabins PV, Munro CA, Meinert CL, Devanand DP, Yesavage J, Mintzer JE, Schneider LS, Pollock BG, Lyketsos CG; CitAD Research Group.

Alzheimers Dement. 2012;8(2):121-30. doi: 10.1016/j.jalz.2011.01.007. Epub 2012 Feb 1.

Memory loss

Flicker LA, Ford AH, Beer CD, Almeida OP.

Med J Aust. 2012 Feb 6;196:114-7. doi: 10.5694/mja11.11399.

Delirium associated with duloxetine in a depressed patient with Alzheimer's dementia

Suzuki Y, Saito M, Someya T.

Psychiatry Clin Neurosci. 2012 Mar;66(2):166. doi: 10.1111/j.1440-1819.2011.02316.x.

Preventing cognitive decline in older African Americans with mild cognitive impairment: design and methods of a randomized clinical trial

Rovner BW, Casten RJ, Hegel MT, Leiby BE.

Contemp Clin Trials. 2012 Jul;33(4):712-20. doi: 10.1016/j.cct.2012.02.016. Epub 2012 Mar 2.

[Psychotropic medication of elderly patients]

Kumagai R, Iseki E.

Nihon Rinsho. 2012 Jan;70(1):140-4.

Age-dependent rescue by simvastatin of Alzheimer's disease cerebrovascular and memory deficits

Tong XK, Lecrux C, Rosa-Neto P, Hamel E.

J Neurosci. 2012 Apr 4;32(14):4705-15. doi: 10.1523/JNEUROSCI.0169-12.2012.

Mixed model of repeated measures versus slope models in Alzheimer's disease clinical trials

Donohue MC, Aisen PS.

J Nutr Health Aging. 2012 Apr;16(4):360-4. doi: 10.1007/s12603-012-0047-7.

Dietary intakes of vitamin E, vitamin C, and β-carotene and risk of Alzheimer's disease: a meta-analysis

Li FJ, Shen L, Ji HF.

J Alzheimers Dis. 2012;31(2):253-8. doi: 10.3233/JAD-2012-120349.

Nonsteroidal anti-inflammatory drug use and the risk of cognitive impairment and Alzheimer's disease

Côté S, Carmichael PH, Verreault R, Lindsay J, Lefebvre J, Laurin D.

Alzheimers Dement. 2012 May;8(3):219-26. doi: 10.1016/j.jalz.2011.03.012.

Gender, sex steroid hormones, and Alzheimer's disease

Vest RS, Pike CJ.

Horm Behav. 2013 Feb;63(2):301-7. doi: 10.1016/j.yhbeh.2012.04.006. Epub 2012 Apr 19.

Efficacy of memantine for agitation in Alzheimer's dementia: a randomised double-blind placebo controlled trial

Fox C, Crugel M, Maidment I, Auestad BH, Coulton S, Treloar A, Ballard C, Boustani M, Katona C, Livingston G.

PLoS One. 2012;7(5):e35185. doi: 10.1371/journal.pone.0035185. Epub 2012 May 2.

Guidelines for the management of cognitive and behavioral problems in dementia

Sadowsky CH, Galvin JE.

J Am Board Fam Med. 2012 May-Jun;25(3):350-66. doi: 10.3122/jabfm.2012.03.100183.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias